Doctor profile · Federal record
Dr. JEFFREY SUGARMAN, M.D., PH.D.
Dermatology Physician (CMS: DERMATOLOGY) · Pediatric Dermatology Physician · Procedural Dermatology Physician · SANTA ROSA, CA
- NPI 1548255482
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2725 MENDOCINO AVE
SANTA ROSA, CA 954032805
(707) 545-4537
fax (707) 545-6726 - Mailing address
-
3536 MENDOCINO AVE, STE 200
SANTA ROSA, CA 954033634
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- March 28, 2017
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #G85304
- Medicaid (2)
- CA #1548255482 · CA #00G853040
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548255482. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,043
Distinct HCPCS
10
Medicare allowed
$577,736
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 10,252 | 3,020 | $41 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 824 | 125 | $8 | |
96900 |
Application of ultraviolet light to skin | 399 | 32 | $27 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 309 | 218 | $95 | |
88304 |
Pathology examination of tissue using a microscope, moderately low complexity | 250 | 127 | $26 | |
17000 |
Destruction of precancer skin growth, 1 growth | 203 | 165 | $60 | |
11102 |
Biopsy of related skin growth, first growth | 136 | 112 | $108 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 113 | 12 | $133 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 100 | 63 | $189 | |
88313 |
Special stained specimen slides to examine tissue including interpretation and report | 63 | 25 | $54 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 332. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$104,534
Transactions
195
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 42 | $33,315.42 | |
| Incyte Corporation | 31 | $21,569.17 | |
| ABBVIE INC. | 54 | $19,403.84 | |
| Evolved By Nature, Inc. | 2 | $8,000.00 | |
| PFIZER INC. | 6 | $7,600.44 | |
| GENZYME CORPORATION | 3 | $4,802.16 | |
| Arcutis Biotherapeutics, Inc. | 8 | $2,439.14 | |
| LNHC, Inc | 4 | $2,349.22 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $2,348.15 | |
| Dermavant Sciences, Inc. | 3 | $1,060.38 | |
| NOBELPHARMA AMERICA, LLC | 1 | $400.00 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $245.43 | |
| Novartis Pharmaceuticals Corporation | 15 | $244.64 | |
| Janssen Biotech, Inc. | 8 | $234.07 | |
| Lilly USA, LLC | 10 | $219.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
137
Patients
51
Total drug cost
$107,335
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 41 | 24 | $298 |
| Hydrocortisone | Generic | 23 | 16 | $113 |
| Clobetasol Propionate | Generic | 21 | 11 | $1,151 |
| Dupixent Pen (Dupilumab) | Brand | 16 | 0 | $60,919 |
| Dupixent Syringe (Dupilumab) | Brand | 12 | 0 | $43,280 |
| Fluocinonide | Generic | 12 | 0 | $287 |
| Tretinoin | Generic | 12 | 0 | $1,287 |